NovaBay Pharmaceuticals Reports 2017 Fourth Quarter and Full Year Financial Results

EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova® for the domestic eye care market, reports financial results for the three and 12 months ended December 31, 2017 and provides a business update. “I’m pleased to announce strong fourth quarter financial performance and full year sales of $18.2 million, which is at the high end of our guidance range,” said Mark M. Sieczkarek, NovaBa

Nanofiber Dressings Speed Up Healing of Serious Wounds

Researchers at Harvard University have come up with two new wound dressings that promote healing without relying on growth factors, cells, or even artificial scaffolds. Instead, natural proteins that are found in soy and human fetus cells are made to speed up the body’s natural healing processes, including performing tricks that only fetal ti (Read more...)

Partial Wave Spectroscopy Spots Cells Turning to Cancer

Detecting cancer in the body usually happens when the disease is already well underway to being mortally dangerous. Although there’s a myriad of cancers and ways to detect them, diagnostic tests typically look for biomarkers produced by tumors. And the bigger the tumor, the more biomarkers it releases, so the bigger it is the easier [… (Read more...)